UT Southwestern Home

UT Southwestern to open DFW’s first state behavioral health hospital this summer: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/dec-texas-behavioral-health-center.html

UT Southwestern Medical Center has been selected to operate the new Texas Behavioral Health Center – the first state acute care behavioral health hospital in the Dallas-Fort Worth area – announcing plans to care for its first patients this summer.

UT Southwestern pharmacologists earn Hill Prize from TAMEST: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/jan-hill-prize-from-tamest.html

David Mangelsdorf, Ph.D., Chair and Professor of Pharmacology and Professor of Biochemistry at UT Southwestern Medical Center, has been awarded the Hill Prize in Biological Sciences from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) in recognition of his long-standing

UT Southwestern pharmacologist named Howard Hughes Medical Institute Investigator: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/july-hhmi-collins.html

James J. Collins III, Ph.D., Associate Professor of Pharmacology at UT Southwestern Medical Center who leads groundbreaking research into the parasitic disease schistosomiasis, has been named a Howard Hughes Medical Institute (HHMI) Investigator.

CRI’s Gerta Hoxhaj, Ph.D., named TAMEST 2025 Mary Beth Maddox Award and Lectureship recipient: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/dec-cri-utsw-tamest-hoxhaj.html

Gerta Hoxhaj, Ph.D., Assistant Professor in Children’s Medical Center Research Institute at UT Southwestern (CRI), is the recipient of the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) 2025 Mary Beth Maddox Award and Lectureship for her research in cancer metabolism.

Director of Simmons Cancer Center, UTSW Pharmacology Chair elected to the National Academy of Medicine: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/oct-nam-arteaga.html

Carlos L. Arteaga, M.D., Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs at UT Southwestern Medical Center, and David Mangelsdorf, Ph.D., Chair and Professor of Pharmacology and Professor of Biochemistry, have been elected to the National Academy

FDA approval of belzutifan culminates 25-year journey at UTSW from gene discovery to a first-in-class drug: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/fda-approval-belzutifan.html

A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.

Children’s Research Institute scientists uncover unique pathway tumors use to acquire antioxidant lipids: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/june-cri-utsw-pathway-tumors-antioxidant-lipids.html

Scientists have discovered tumors can tap a nontraditional pathway to acquire lipoproteins – molecules that transport fat in blood – which enriches cancer cells with an antioxidant shield to survive stress, according to new research from Children’s Medical Center Research Institute at UT

Search